Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.49 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.49 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.49 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NSD2 | O96028 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4396367 | 0.88 | ASAH1 (0.50) | ELANETDP1MAPTKMT2ALMNA | |
| SCHEMBL4395757 | 0.83 | EPHX1 (0.49) | — | |
| SCHEMBL3252190 | 0.83 | PRSS1 (0.54) | CYP19A1PRSS1PRSS2PRSS3ELANE | |
| SCHEMBL153387 | 0.81 | CYP19A1 (0.55) | CYP19A1PRSS1PRSS2PRSS3ELANE | |
| SCHEMBL43742 | 0.81 | KMT2A (0.61) | CYP19A1PRSS1PRSS2PRSS3ELANE | |
| SCHEMBL6247100 | 0.81 | PRSS1 (0.61) | CYP19A1PRSS1PRSS2PRSS3ELANE | |
| SCHEMBL4643345 | 0.80 | KMT2A (0.45) | ELANETDP1HSD17B10MAPTALDH1A1 | |
| SCHEMBL11495143 | 0.79 | CYP19A1 (0.53) | CYP19A1PRSS1PRSS2PRSS3ELANE | |
| SCHEMBL231450 | 0.79 | CYP19A1 (0.53) | CYP19A1PRSS1PRSS2PRSS3ELANE | |
| SCHEMBL2141580 | 0.79 | CYP19A1 (0.53) | CYP19A1PRSS1PRSS2PRSS3ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2737927-B1 | Imidazo[1,2a]pyrazines and compositions comprising them for the treatment of parasitic diseases | NOVARTIS AG (CH) | 2016-03-30 | — | — | EP | claimed |
| US-7960380-B2 | Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators | ASTRAZENECA AB (SE) | 2011-06-14 | — | — | US | claimed |
| US-20100227847-A1 | Non-Anilinic Derivatives Of Isothiazol-3(2H)-one 1,1-Dioxides As Liver X Receptor Modulators | ASTRAZENECA AB (SE) | 2010-09-09 | — | — | US | claimed |
| US-7723333-B2 | Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulators | ASTRAZENECA AB (SE) | 2010-05-25 | — | — | US | claimed |
| US-20090005353-A1 | Non-Anilinic Derivatives of Isothiazol-3(2H)-one 1,1-Dioxides as Liver X Receptor Modulators | ASTRAZENECA AB (SE) | 2009-01-01 | — | — | US | claimed |
| CN-101137628-A | Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators | ASTRAZENECA AB (SE) | 2008-03-05 | — | — | CN | claimed |
| EP-1838687-A1 | NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS | AstraZeneca AB (SE) | 2007-10-03 | — | — | EP | claimed |
| WO-2006073366-A1 | NON-ANILINIC DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS | ASTRAZENECA AB (SE) | 2006-07-13 | — | — | WO | claimed |
| EP-0843220-B1 | Radiation sensitive resin composition | JSR CORP (JP) | 2003-02-19 | — | — | EP | claimed |
| US-5994022-A | BECOMES SOLUBLE IN ALKALI DEVELOPING SOLUTION BY ACTION OF AN ACID | JSR CORPORATION (JP) | 1999-11-30 | — | — | US | claimed |
| EP-0843220-A1 | Radiation sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1998-05-20 | — | — | EP | claimed |
| US-5283326-A | Coupling azo and cyanine dyes; colorfastness, heat resistance | SANDOZ AG (CH) | 1994-02-01 | — | — | US | claimed |
| US-4837269-A | FIBER-REACTIVE DISAZO DYES | BASF AKTIENGESELLSCHAFT (DE) | 1989-06-06 | — | — | US | claimed |
| US-4751288-A | COLORFASTNESS | BASF AKTIENGESELLSCHAFT (DE) | 1988-06-14 | — | — | US | claimed |
| US-4619992-A | IMPROVED COLORFASTNESS | BASF AKTIENGESELLSCHAFT (DE) | 1986-10-28 | — | — | US | claimed |
| US-4496480-A | Isothiazolazo dyes having coupling components which are free from unsaturated aliphatic radicals | BASF AKTIENGESELLSCHAFT (DE) | 1985-01-29 | — | — | US | claimed |
| US-4413000-A | BACTERICIDES | BEECHAM GROUP LIMITED (GB) | 1983-11-01 | — | — | US | claimed |
| US-20240239922-A1 | PHOTOCURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-4086208-A | Flame resistant polyesters | TOYO BOSEKI KABUSHIKI KAISHA (JA) | 1978-04-25 | — | — | US | disclosed |
| US-4066615-A | PHOTOSTABILITY, THERMAL STABILITY | SANKYO COMPANY LIMITED (JA) | 1978-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090005353-A1 | Non-Anilinic Derivatives of Isothiazol-3(2H)-one 1,1-Dioxides as Liver X Receptor Modulators | NR1H2, NR1H3, NR1I2 | CYP19A1 184/4885PRSS1 3159/4885PRSS2 2779/4885 |
| US-20100227847-A1 | Non-Anilinic Derivatives Of Isothiazol-3(2H)-one 1,1-Dioxides As Liver X Receptor Modulators | NR1H2, NR1H3, NR1I2 | CYP19A1 184/4885PRSS1 3159/4885PRSS2 2779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.